Bristol Myers Squibb (BMY) reported $11.89 billion in revenue for the quarter ended September 2024, representing a year-over-year increase of 8.4%. EPS of $1.80 for the same period compares to $2.00 a year ago.The reported revenue represents a surprise of +5.07% over the Zacks Consensus Estimate of $11.32 billion. With the consensus EPS estimate being $1.49, the EPS surprise was +20.81%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations ...